Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up1.00% Nasdaq Up1.29%

Celldex Therapeutics, Inc. (CLDX)

-NasdaqGS
14.69 0.96(6.99%) Apr 16, 4:00PM EDT
|After Hours : 14.60 Down 0.09 (0.61%) Apr 16, 7:43PM EDT
Get the big picture on all your investments.
Research ReportsGet Research Reports for:
Recent Reports
ReleasedContributorAuthorTitlePagesPrice
Apr 16, 2014Pechala's ReportsLubomir PechalaCELLDEX THERAPEUTICS INC (CLDX) - REPORT FOR ACTIVE TRADERS1$25
Apr 15, 2014ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$49
Apr 15, 2014New Constructs, LLCN/ACLDX: Due Diligence Review: Forensic Earnings and Valuation5$25
Apr 11, 2014S&P Capital IQ Quantitative ReportN/ACelldex Therapeutics11$126.50
Apr 11, 2014Pechala's ReportsFrantisek PechalaCELLDEX THERAPEUTICS INC (CLDX) 12-months forecast1$15
Apr 10, 2014Ford Investor Services, Inc.N/AValue Graph: CELLDEX THERAPEU -- CLDX1$11.50
Apr 10, 2014Ford Investor Services, Inc.N/AIndustry Value Graph: ATHX , CLDX , CRIS , INO , PPHM -- DRUGS3$34.50
Apr 10, 2014Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of CELLDEX THERAPEUTICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20
Apr 9, 2014ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for CLDX11$25
Apr 9, 2014Zacks Investment Research Inc.N/ACELLDEX THERAPT (CLDX) Zacks Company Snapshot1$11.50

View All Reports for CLDX ...